Deepali Chaugule

Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)

Vikas Ostwal, Sarika Mandavkar, Prabhat Bhargava et al. · Journal of Clinical Oncology · 2023 · 34 citations

Medicine, Oncology, Pharmacology +17

A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study)

Vikas Ostwal, Anant Ramaswamy, Prabhat Bhargava et al. · Medical Oncology · 2022 · 31 citations

Medicine, Oncology, Pharmacology +13

Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy

Vikas Ostwal, Anant Ramaswamy, Sarika Mandavkar et al. · JAMA Network Open · 2024 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer

Vikas Ostwal, Shraddha Patkar, Reena Engineer et al. · JAMA Oncology · 2024 · 17 citations · Full text

Medicine, Oncology, Surgery +17